When Cuts Cost More: Projected Fiscal Impact of Eliminating the AIDS Drug Assistance Program in 30 US States

  1. Ryan M. Forster
  2. Melissa Schnure
  3. Ruchita Balasubramanian
  4. Joyce L. Jones
  5. Emily P. Hyle
  6. Scott Batey
  7. Keri N Althoff
  8. Kelly Gebo
  9. David W. Dowdy
  10. Maunank Shah
  11. Anthony T. Fojo
  12. Parastu Kasaie
Read the full article

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Across 30 US states and the District of Columbia, eliminating the AIDS Drug Assistance Program is projected to save $8.32 billion in direct costs while generating $14.89 billion in downstream HIV care costs attributable to excess incident infections from 2026-2035. Costs are projected to surpass savings within six years.

Article activity feed

  1. Version published to 10.64898/2026.07.27.26359045 on medRxiv